Company Filing History:
Years Active: 1989-2002
Title: Charles Meyer Radding: Innovator in Rad51 Research
Introduction
Charles Meyer Radding is a notable inventor based in Hamden, CT (US). He has made significant contributions to the field of molecular biology, particularly in the study of Rad51. With a total of 4 patents, Radding's work focuses on methods and compositions that have the potential to impact disease diagnosis and treatment.
Latest Patents
Radding's latest patents include innovative methods and compositions utilizing Rad51. One patent provides compositions and methods for identifying and diagnosing individuals at risk for a disease state associated with aberrant Rad51 foci. Another patent focuses on identifying agents that bind to or modulate Rad51, showcasing his commitment to advancing medical research.
Career Highlights
Radding is affiliated with Yale University, where he continues to conduct research and develop new methodologies in his field. His work has garnered attention for its potential applications in understanding and treating various diseases.
Collaborations
Radding has collaborated with esteemed colleagues, including David C Ward and Efim Ilya Golub, further enhancing the impact of his research through teamwork and shared expertise.
Conclusion
Charles Meyer Radding's contributions to Rad51 research exemplify the importance of innovation in the medical field. His patents and ongoing work at Yale University highlight his dedication to improving disease diagnosis and treatment.